JointHealth™ express November 15, 2007
ACE is speaking out on behalf of people living with ankylosing spondylitis in Saskatchewan. The government of Saskatchewan has declined to list any of the three biologic response modifiers approved by Health Canada to treat ankylosing spondylitis. Yesterday Cheryl Koehn, the president of ACE, held a press conference to bring attention to the issue of discrimination against people living with ankylosing spondylitis, and all forms of arthritis in Canada.
Please click here to read and listen to press coverage of this event.
Once you have gone through this vitally important information, we urge you to help us stand up for the people in Saskatchewan who live with ankylosing spondlyitis and are being denied the best treatments available. Here is how you can you help:
ACE is speaking out on behalf of people living with ankylosing spondylitis in Saskatchewan. The government of Saskatchewan has declined to list any of the three biologic response modifiers approved by Health Canada to treat ankylosing spondylitis. Yesterday Cheryl Koehn, the president of ACE, held a press conference to bring attention to the issue of discrimination against people living with ankylosing spondylitis, and all forms of arthritis in Canada.
Please click here to read and listen to press coverage of this event.
Once you have gone through this vitally important information, we urge you to help us stand up for the people in Saskatchewan who live with ankylosing spondlyitis and are being denied the best treatments available. Here is how you can you help:
- Forward this email to as many people as you can
- Write a letter to the editors of the Regina Leader-Post letters@leaderpost.canwest.com and the Saskatoon StarPhoenix spnews@SP.canwest.com, in support of ACE's activities in Saskatchewan.
Arthritis Consumer Experts
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealth™ information and education programs.